logo

Stock Screener

Forex Screener

Crypto Screener

CVS

CVS Health Corporation (CVS)

$

64.78

-0.84 (-1.30%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

4.7113

Market cap

Market cap

81.9 Billion

Price to sales ratio

Price to sales ratio

0.2162

Debt to equity

Debt to equity

1.0557

Current ratio

Current ratio

0.8227

Income quality

Income quality

2.5303

Average inventory

Average inventory

17.7 Billion

ROE

ROE

0.0698



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.01 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $8,516,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $51,401,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $65.62 suitable for budget-conscious investors, while its high average trading volume of 8,794,998.00 indicates strong liquidity. With a large market capitalization of $81,947,995,600.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.

What is CVS Health Corporation (CVS)'s current stock price?

The current stock price of CVS Health Corporation (CVS) is $64.78 as of 2025-07-11. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict CVS Health Corporation stock to fluctuate between $43.56 (low) and $72.51 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-07-11, CVS Health Corporation's market cap is $81,947,995,600, based on 1,265,020,000 outstanding shares.

Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.

CVS Health Corporation pays dividends. The current dividend yield is 5.13%, with a payout of $0.67 per share.

To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

CVS Health Corporation's last stock split was 2:1 on 2005-06-07.

Revenue: $372,809,000,000 | EPS: $3.66 | Growth: -43.61%.

Visit https://www.cvshealth.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CVS

zacks.com

Here's Why CVS Health (CVS) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CVS

zacks.com

Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?

CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

CVS

reuters.com

Judge orders CVS' Omnicare unit to pay $949 million over invalid prescriptions

A federal judge ordered CVS Health's Omnicare unit to pay $948.8 million in penalties and damages, in a whistleblower lawsuit claiming it fraudulently billed the U.S. government for invalid drug prescriptions.

CVS

prnewswire.com

CVS Health declares quarterly dividend

WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

CVS

zacks.com

Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?

CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported by seasonal trends, including the impact of high vaccine demand and a longer-than-usual flu season.

CVS

benzinga.com

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

CVS

zacks.com

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know

CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.

CVS

zacks.com

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CVS

zacks.com

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

CVS

youtube.com

CVS drops Lilly's Zepbound

CNBC's Angelica Peebles reports on news regarding CVS.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener